Faylene Lunn Faylene Lunn

Teva Canada in the Federal Court’s strike of judicial review by Novo Nordisk Canada Inc.

In 2019-2020 Osler successfully represented Teva Canada in a judicial review application brought by Novo Nordisk Canada Inc. in respect of a decision of the Minister of Health concerning Teva’s drug submission for liraglutide. The application was struck, providing a...

Lead Office: Toronto Date Closed: -- Value: -

Mylan Pharmaceuticals in a patent proceeding brought by Amgen

Osler successfully represented Mylan Pharmaceuticals in a patent proceeding brought by pharmaceutical company Amgen to prohibit the Minister of Health from issuing a market authorization (notice of compliance) to Mylan for its generic version of the drug SENSIPAR^® (cinacalcet...

Lead Office: Ottawa Date Closed: November 3, 2015 Value: -

Federal Court Rules in Favour of Mylan Pharmaceuticals ULC in Pantoprazole Magnesium Patent Case

Osler successfully represented Mylan Pharmaceuticals in a patent proceeding against pharmaceutical company Takeda to prohibit the Minister of Health from issuing a market authorization (notice of compliance) to Mylan for its generic version of the drug TECTA®...

Lead Office: Ottawa Date Closed: June 15, 2015 Value: -